tiprankstipranks
Trending News
More News >

MedTechBio Profile - Seeking Alpha Blogger

4 Followers
tipranks
MedTechBio

MedTechBio
Seeking Alpha

Financial Blogger
#27,166 out of 32,198 Financial Bloggers
#36,936 out of 42,279 experts

Success Rate

27%
4 out of 15 ratings made a profit

Average Return

-34.20%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying MedTechBio's trades since 2015 and holding each position for 1 Year would result in 26.67% of your transactions generating a profit, with an average return of -34.2% per rating.

Stock Rating Distribution

15Ratings
93.33% Bullish
6.67% Bearish
0.00% Neutral
Distribution of MedTechBio's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United States

Best Rating

Stock:
Incyte
(INCY)
Rating:Sell
Date:Jun 18, 2015 - Jun 18, 2016
Return:+29.10%
The most profitable rating made by MedTechBio

MedTechBio's Stock Coverage

Company Name
Date
Position
No. of Ratings
Success Rate
Avg Return
Incyte
Jun 18, 2015
Bearish
1Ratings
100%
+29.10%
Nabriva Therapeutics
Dec 18, 2017
Bullish
1Ratings
0%
-71.20%
Talphera
Jan 03, 2018
Bullish
1Ratings
100%
+23.80%
ATRS
Antares Pharma
Jan 03, 2018
Bullish
1Ratings
100%
+23.80%
Lineage Therap
Feb 21, 2018
Bullish
1Ratings
0%
-47.70%
Geron
Mar 21, 2018
Bullish
4Ratings
25%
-29.45%
Rigel
Apr 25, 2018
Bullish
1Ratings
0%
-38.20%
Novavax
May 02, 2018
Bullish
1Ratings
0%
-67.00%
DXC Technology
May 31, 2018
Bullish
1Ratings
0%
-39.70%
DMK Pharmaceuticals
Apr 25, 2019
Bullish
3Ratings
0%
-69.50%
List of latest recommendations made by MedTechBio. Click to expand and see MedTechBio's performance on a particular stock
Disclaimer: TipRanks collects ratings of bloggers by scanning publicly available reports on financial websites and by receiving reports directly from the bloggers or from our users. The information displayed might not be accurate or up to date. The displayed ratings are made entirely at the sole discretion of the bloggers. TipRanks holds no liability over the bloggers information or opinions expressed on the site.